About the HIV 4th-Generation Duo Antigen/Antibody Test
Purpose of the test
Human Immunodeficiency Virus (HIV) often causes no symptoms for years. Testing is the only reliable way to know your status.
Untreated HIV attacks the immune system and can progress to AIDS (acquired immunodeficiency syndrome). Early detection lets treatment start sooner, which prevents progression to AIDS and protects your long-term immune health. According to the CDC’s HIV testing guidance, knowing your status is the essential first step toward treatment and prevention.
HIV can pass through blood, semen, vaginal fluids, rectal fluids, and breast milk. It can also pass from parent to baby during pregnancy, delivery, or breastfeeding. When HIV is treated and suppressed to undetectable levels, it can’t be transmitted sexually. That’s the U=U principle: Undetectable = Untransmittable, and is known as Treatment as Prevention (TasP).
- Screening: The CDC recommends routine HIV screening for all adults and adolescents, with more frequent testing for sexually active people at higher risk.
- Diagnosis: Ordered when you’ve had a potential exposure or have symptoms of acute HIV infection, like fever, rash, or swollen lymph nodes, within two to four weeks of exposure.
- Monitoring: Establishes HIV status before starting pre-exposure prophylaxis (PrEP: daily medication or bimonthly injection that can prevent contracting HIV, for HIV-negative people ) or after a possible exposure requiring post-exposure prophylaxis (PEP: 28-day course of antiretroviral medication given after a potential exposure such as sexual assault, condom breakage, or sharing of needles).
The 4th-generation test is currently the most sensitive test for HIV, but it doesn’t detect HIV immediately after exposure. No HIV test can. It doesn’t distinguish between HIV-1 and HIV-2, measure a viral load, provide a CD4 count, or screen for other STIs.
What does the HIV 4th-Generation Duo Antigen/Antibody Test measure?
The 4th-generation HIV test uses an immunoassay to detect two distinct markers in a blood sample at the same time.
- 4th generation antigen/antibody (Ag/Ab) immunoassay: Detects both HIV-1 and HIV-2 antibodies and the HIV p24 antigen from a single blood draw. The p24 antigen is a viral protein produced in high amounts shortly after infection, often before antibodies develop. Combining both markers gives this test a shorter window period (18 to 45 days) than older tests. This is the CDC-recommended standard for routine HIV screening, processed at a CLIA-certified laboratory.
- 3rd generation antibody-only test: Detects HIV-1 and HIV-2 antibodies but not the p24 antigen. It has a longer window period (roughly 23 to 90 days) and is less commonly used now that 4th-generation tests are standard.
- HIV RNA (NAT) test: Detects HIV genetic material directly. Can find infection as early as 10 to 33 days after exposure. Not used for routine screening because of its complexity and cost. Reserved for high-risk exposures, blood supply screening, or indeterminate 4th-generation results.
- HIV-1/HIV-2 antibody differentiation assay (confirmatory): Not a screening test. The lab runs this automatically when your initial Ag/Ab result is reactive. It tells the lab whether the infection is HIV-1 or HIV-2. If the differentiation assay is indeterminate, an HIV-1 RNA test follows. This two-step process is part of the CDC HIV diagnostic algorithm.
Results come back as “reactive” or “non-reactive,” not “positive” or “negative.” The results section covers what each term means.
When should I get an HIV 4th-generation test?
Consider testing if any of these apply:
- Flu-like symptoms (fever, sore throat, rash, or swollen lymph nodes) within two to four weeks of a possible exposure
- A recent potential exposure through unprotected sex, shared needles, or other contact with blood or body fluids
- A sexual partner recently diagnosed with HIV or another STI
- Multiple sexual partners or a new partner whose HIV status you don’t know
- Current or recent injection drug use, including shared equipment
- A new STI diagnosis (STIs raise HIV transmission risk), hepatitis, or tuberculosis
- A current pregnancy or plans to become pregnant
- No prior HIV test ever
For routine screening, the U.S. Preventive Services Task Force and the CDC recommend:
- All adults and adolescents aged 13 to 64, at least once as part of routine healthcare
- Gay, bisexual, and other men who have sex with men (MSM), at least annually; every three to six months if at higher risk
- People who inject drugs or share injection equipment at least annually
- Anyone with a new STI diagnosis or a partner with HIV at least annually
- Pregnant people, at every pregnancy, as early as possible in prenatal care
If you had a high-risk exposure in the last 72 hours, ask a provider or emergency room about PEP right away. PEP is a short course of antiretroviral medication that can prevent HIV infection if started within 72 hours of exposure.
How It Works
How to get tested
This test is available through CLIA-certified labs including LabCorp and Quest Diagnostics. Visit a nearby patient service center for a blood draw. Results are sent to your secure online account with an email notification.
Prefer to test privately at home? At-home HIV tests ship a self-collection kit with prepaid return shipping. Most at-home HIV tests use a different method (antibody-only) and have a longer window period than the 4th-generation Ag/Ab test.
This test is also available through a provider’s office, clinic, or hospital lab.
Before the test
No fasting required. Eat and drink normally.
Stop taking biotin supplements at least 72 hours before your appointment. Biotin goes by several names: vitamin B7, vitamin B8, vitamin H, and coenzyme R. Biotin plays a role in producing keratin and is used as a supplement in many hair, skin, and nail products. Biotin can interfere with immunoassay-based tests and affect your results. Tell the lab technician about any supplements or medications you take.
There aren’t any restrictions on food, alcohol, or exercise. Wear a short-sleeved shirt or clothing with sleeves that roll up easily. If you’re on antiretroviral therapy (ART) for HIV prevention or treatment, let your ordering provider know before testing, as ART may affect your test results.
During the test
A technician draws blood from a vein in your arm. The draw takes a few minutes. A small bandage covers the site afterward. No urine samples, swabs, or physical exams are involved.
Most people feel a brief pinch or pressure. Some feel lightheaded afterward. Tell the technician if you feel faint. You can go back to normal activities right away.
Keep the bandage on for at least 15 minutes. A small bruise at the draw site is normal and clears up within a few days. Call your provider if you notice lasting pain, significant swelling, or signs of infection (redness, warmth, or discharge).
After the test
Results are ready within one to three business days after the lab receives your sample. They’ll appear in your secure online account with an email notification.
If your initial result is reactive, the lab automatically runs a confirmatory HIV-1/HIV-2 antibody differentiation assay on the same sample before releasing your final result. This may add a small amount of time. If your test was ordered through a provider’s office, result timing depends on their system.
What Do My Results Mean?
The 4th generation HIV test reports results as “reactive” or “non-reactive” rather than “positive” or “negative.” A reactive initial result automatically triggers a confirmatory test (the HIV-1/HIV-2 antibody differentiation assay) on the same blood sample before a final result is released.
If your results are non-reactive (negative)
No HIV antibodies or p24 antigen were detected. If you tested at least 45 days after your most recent possible exposure, a non-reactive result is generally considered conclusive per CDC HIV diagnosis and testing guidance.
Here’s what the timing means:
- Before 18 days: The result may not be reliable. The test can miss an early infection.
- 18 to 44 days: The result is likely accurate but not yet final. Retest at the 45-day mark if your exposure was confirmed.
- 45 days or later: The result is generally considered conclusive. No further retesting is needed for that exposure.
If your first result is non-reactive and your exposure was within the last 45 days, retest after the 45-day mark. Testing early is fine. An early non-reactive result doesn’t mean you’re uninfected, but it gives you a starting point.
If your results are reactive (positive)
The initial test detected HIV markers. The lab automatically runs a confirmatory HIV-1/HIV-2 antibody differentiation assay on the same sample. A reactive initial result isn’t a confirmed HIV diagnosis until the confirmatory assay is complete.
The differentiation assay shows whether the infection is HIV-1, HIV-2, or indeterminate. If indeterminate, the lab runs an HIV-1 RNA NAT test as the final step. That’s the full CDC diagnostic algorithm.
False positives can happen with immunoassay-based tests. Certain autoimmune conditions or recent vaccinations can trigger them. The confirmatory algorithm is designed to rule out false positives before any diagnosis is confirmed. As Mayo Clinic notes, an HIV/AIDS diagnosis requires confirmation beyond an initial screening result.
If the confirmatory process shows a true HIV infection, treatment is highly effective. ART can suppress HIV to undetectable levels. When HIV is undetectable, it can’t be transmitted sexually (U=U). Let recent sexual partners know so they can get tested. Many health departments offer confidential partner notification services. Ask your provider about starting ART as soon as possible.
FAQs
Sources
CDC HIV Nexus. HIV Diagnosis and Testing. 2025.
CDC. Sexually Transmitted Infections Treatment Guidelines, 2021: Screening Recommendations. 2021.
U.S. Preventive Services Task Force. Recommendation Topics. 2025.